Matter Neuroscience
Latest round
- Series B
Last raised
- Nov 2022
Total raised
- $19M
Investors
- 4
About Matter Neuroscience
Based in Colorado, US, and co-founded by Axel Bouchon, Ben Goldhirsh, and Chris Shiflett in 2019, Matter Neuroscience Inc. operates as a healthcare company that specializes in developing treatment for neurological disorders. The company provides personalized information on the brain chemistry of patients and develops treatments for brain disorders. Matter Neuroscience, also identifies the biomarkers for happiness. The firm offers an application, that utilizes molecular-level insights on dopamine, oxytocin, and cannabinoids, to help users understand how experiences influence neurotransmitter activity in their brains. By capturing and reflecting on positive experiences, Matter aims to foster neuroplasticity for personal growth, creativity, and empathy. Long-term goals include correlating higher neuroplasticity levels with enhanced well-being and longevity.
Who invested in Matter Neuroscience
4 investors across 1 round
See all investors in Matter Neuroscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 3, 2022
Amount
$19M
Investors
Questions about Matter Neuroscience
Who invested in Matter Neuroscience?
Matter Neuroscience has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Matter Neuroscience raised?
Matter Neuroscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Matter Neuroscience last raise money?
Matter Neuroscience's most recent round on record is a Series B, in Nov 2022.
What does Matter Neuroscience do?
Based in Colorado, US, and co-founded by Axel Bouchon, Ben Goldhirsh, and Chris Shiflett in 2019, Matter Neuroscience Inc.
Where is Matter Neuroscience headquartered?
Matter Neuroscience is headquartered in Boulder, US.
Which VCs invest in companies like Matter Neuroscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Matter Neuroscience's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Matter Neuroscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.